Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of the Efficacy and Safety of the Microbicide Carraguard® in Preventing HIV Seroconversion in Women

NCT00213083 is registered in ClinicalTrials.gov with Population Council as lead sponsor.

NCT NCT00213083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00213083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of the Efficacy and Safety of the Microbicide Carraguard® in Preventing HIV Seroconversion in Women
Lead sponsor
Population Council
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2007
Enrollment
6,203 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aids, hiv infections, hiv seroconversion, sexually transmitted diseases